DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,008 filers reported holding DANAHER CORPORATION in Q1 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,235,185 | -18.5% | 10,621 | -0.2% | 0.43% | -15.2% |
| Q2 2023 | $2,743,989 | +10.1% | 10,641 | -4.0% | 0.51% | +4.8% |
| Q1 2023 | $2,493,109 | -14.5% | 11,081 | -0.4% | 0.48% | -13.4% |
| Q4 2022 | $2,914,829 | +1.8% | 11,128 | +0.4% | 0.56% | -15.6% |
| Q3 2022 | $2,863,000 | -3.3% | 11,085 | -5.1% | 0.66% | +3.6% |
| Q2 2022 | $2,961,000 | -8.3% | 11,678 | +6.1% | 0.64% | +6.7% |
| Q1 2022 | $3,230,000 | -9.9% | 11,011 | +1.0% | 0.60% | -4.9% |
| Q4 2021 | $3,585,000 | +7.0% | 10,897 | -0.9% | 0.63% | -0.6% |
| Q3 2021 | $3,349,000 | +16.7% | 11,000 | +2.9% | 0.63% | +7.6% |
| Q2 2021 | $2,869,000 | +7.5% | 10,692 | -9.8% | 0.59% | +8.1% |
| Q1 2021 | $2,669,000 | -7.1% | 11,858 | -8.3% | 0.54% | -10.8% |
| Q4 2020 | $2,873,000 | +1.5% | 12,934 | -1.6% | 0.61% | -6.9% |
| Q3 2020 | $2,830,000 | +16.8% | 13,143 | -4.1% | 0.66% | +7.5% |
| Q2 2020 | $2,423,000 | +18.0% | 13,705 | -7.6% | 0.61% | -0.2% |
| Q1 2020 | $2,054,000 | -45.8% | 14,839 | -39.9% | 0.61% | -36.0% |
| Q4 2019 | $3,788,000 | +4.0% | 24,680 | -2.2% | 0.95% | -3.0% |
| Q3 2019 | $3,644,000 | -2.3% | 25,228 | -3.3% | 0.98% | -9.9% |
| Q2 2019 | $3,729,000 | -12.6% | 26,093 | -19.3% | 1.09% | -15.9% |
| Q1 2019 | $4,266,000 | +13.5% | 32,314 | -6.6% | 1.30% | +9.8% |
| Q4 2018 | $3,759,000 | 0.0% | 34,590 | 0.0% | 1.18% | -0.1% |
| Q3 2018 | $3,759,000 | +10.1% | 34,590 | +0.0% | 1.18% | +0.6% |
| Q2 2018 | $3,413,000 | +4.9% | 34,582 | +4.0% | 1.18% | +2.4% |
| Q1 2018 | $3,255,000 | -44.0% | 33,249 | -48.9% | 1.15% | +2.3% |
| Q4 2017 | $5,810,000 | +112.7% | 65,011 | +104.2% | 1.12% | +2.3% |
| Q3 2017 | $2,731,000 | -45.4% | 31,840 | -46.3% | 1.10% | -48.2% |
| Q2 2017 | $5,003,000 | +1.8% | 59,279 | +3.2% | 2.12% | -5.7% |
| Q1 2017 | $4,915,000 | +13.3% | 57,468 | +3.1% | 2.24% | -0.0% |
| Q4 2016 | $4,339,000 | +3.8% | 55,738 | +4.5% | 2.25% | -1.1% |
| Q3 2016 | $4,181,000 | -16.7% | 53,330 | +7.4% | 2.27% | -26.1% |
| Q2 2016 | $5,017,000 | +6.5% | 49,672 | -0.0% | 3.08% | +0.1% |
| Q1 2016 | $4,712,000 | +5.0% | 49,676 | +2.8% | 3.07% | +11.6% |
| Q4 2015 | $4,488,000 | +13.2% | 48,318 | +3.9% | 2.75% | +5.4% |
| Q3 2015 | $3,963,000 | +6.7% | 46,508 | +7.2% | 2.61% | +11.8% |
| Q2 2015 | $3,713,000 | – | 43,383 | – | 2.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |